Kommersiellt obunden läkemedelsinformation riktad till läkare och sjukvårdspersonal

Janusmed Sex and Gender

News

Vaccine against covid-19
The knowledge bank now contains sex-specific information on vaccines against covid-19 (ATC code J07BX).
06/16/2021

Clear sex differences in risk of severe covid-19
Men have a higher risk of inpatient care, intensive care and death in covid-19 than women, according to a new report (in Swedish) from the Center for Epidemiology and Community Medicine (CES). Largest sex difference is seen in the age group 50-64 years. The excess risk among men are not explained by previous morbidity or socioeconomic factors, instead biological sex differences are believed to be of importance.
04/20/2021

More women have reported adverse events after covid-19 vaccination
Among the adverse events after covid-19 vaccination reported to the Swedish Medical Products Agency, significantly more are reported by women than by men, according to the Swedish Gender Equality Agency (in Swedish). However, the number of reports are few and the adverse events are not considered to be serious. Possible explanations for the sex differences may be that women have more adverse events, women are more likely to report adverse events, or that more women have been vaccinated.
03/16/2021

Women are more likely to suffer from healthcare injuries in psychiatry
A review of 4,000 medical records conducted by Swedish Association of Local Authorities and Regions shows that 18 percent of women and 12 percent of men received a health care injury, according to the Radio Sweden (in Swedish). A healthcare injury can be that the patient receives the wrong diagnosis or the wrong medication.
03/12/2021

Read more news here!

Janusmed Sex and Gender is a knowledge bank with structured information on sex and gender aspects on drug treatment. The information is aimed towards healthcare personal. It is possible to search on generic names in English and trade names of drug products on the Swedish market. For detailed information on how to search, click on Search help in the blue search field. The purpose of the web site is to improve drug treatment by providing information on whether drug choice or drug dosing need to consider the patient's sex.

Please note that Janusmed Sex and Gender does not include information on teratogenic effects or compatibility with breast feeding. For this information, please consult the knowledge databases Janusmed Drugs and Birth Defects and Janusmed Drugs and Breastfeeding, respectively (in Swedish).

The Health and Medical Care Administration at Region Stockholm is responsible for the web site. The work is done in collaboration between the Drug Therapeutic Committee in Region Stockholm, Department of Clinical Pharmacology, Karolinska University Hospital and Centre for Gender Medicine, Karolinska Institutet.

Engelsk flagga

Searchable substances

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z